Atay Oguzhan sold $604K of BLLN (indirect holdings)
Atay Oguzhan (Chairman and CEO) sold 5,334 indirectly-held shares of BillionToOne, Inc. (BLLN) at $113.17 ($0.60M total) across 2 trades on 2026-11-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale reduces insider ownership and may be interpreted as a signal, but the pre‑arranged nature tempers its significance.
Market read
The filing provides fresh, material information for BLLN shareholders and may cause short‑term price movement.
What to watch
Potential upcoming financing needs or strategic repositioning not disclosed in the filing.
Background
Form 4 filings disclose insider transactions and are primary sources for insider activity.
Ticker impact
CEO Atay Oguzhan sold $604K of BLLN shares via a 10b5‑1 plan, reducing his stake to 141,167 shares.
likely slight downward pressure as the market prices in the insider sell.
A $600K sale by the chairman/CEO is material for a micro‑cap, but the amount is modest relative to market cap and the sale was pre‑arranged.
Market effects
Minimal impact on the broader biotech/AI sector; the sale is company‑specific.
No regional effect; the filing is U.S. SEC‑based.
Limited global relevance; only relevant to investors tracking BLLN.
Counterpoint
The sale could be a routine liquidity event and not indicative of negative fundamentals.
Key entities
- companyBillionToOne, Inc.
Public biotech/AI company listed on NASDAQ under ticker BLLN.
- personAtay Oguzhan
Chairman and CEO of BillionToOne, Inc., reporting the insider sale.

